phentermine hydrochloride

Generic: phentermine hydrochloride

Labeler: northwind pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name phentermine hydrochloride
Generic Name phentermine hydrochloride
Labeler northwind pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

phentermine hydrochloride 37.5 mg/1

Manufacturer
Northwind Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 51655-875
Product ID 51655-875_486f8bbf-f409-00ff-e063-6294a90a34c3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040526
DEA Schedule civ
Marketing Start 2014-05-15
Marketing End 2026-06-30

Pharmacologic Class

Classes
appetite suppression [pe] increased sympathetic activity [pe] sympathomimetic amine anorectic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655875
Hyphenated Format 51655-875

Supplemental Identifiers

RxCUI
803353
UNII
0K2I505OTV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phentermine hydrochloride (source: ndc)
Generic Name phentermine hydrochloride (source: ndc)
Application Number ANDA040526 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 37.5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, DISPENSING (51655-875-24)
  • 60 TABLET in 1 BOTTLE, DISPENSING (51655-875-25)
  • 45 TABLET in 1 BOTTLE, DISPENSING (51655-875-90)
source: ndc

Packages (3)

Ingredients (1)

phentermine hydrochloride (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "486f8bbf-f409-00ff-e063-6294a90a34c3", "openfda": {"unii": ["0K2I505OTV"], "rxcui": ["803353"], "spl_set_id": ["d1d74574-9ebc-45fc-86e9-8cbd59acacd4"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, DISPENSING (51655-875-24)", "package_ndc": "51655-875-24", "marketing_end_date": "20260630", "marketing_start_date": "20140515"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE, DISPENSING (51655-875-25)", "package_ndc": "51655-875-25", "marketing_end_date": "20260630", "marketing_start_date": "20140515"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE, DISPENSING (51655-875-90)", "package_ndc": "51655-875-90", "marketing_end_date": "20260630", "marketing_start_date": "20140515"}], "brand_name": "Phentermine Hydrochloride", "product_id": "51655-875_486f8bbf-f409-00ff-e063-6294a90a34c3", "dosage_form": "TABLET", "pharm_class": ["Appetite Suppression [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "51655-875", "dea_schedule": "CIV", "generic_name": "Phentermine Hydrochloride", "labeler_name": "Northwind Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine Hydrochloride", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "ANDA040526", "marketing_category": "ANDA", "marketing_end_date": "20260630", "marketing_start_date": "20140515"}